Emmaus Life Sciences (EMMA) Liabilities and Shareholders Equity (2010 - 2026)
Emmaus Life Sciences (EMMA) posted Liabilities and Shareholders Equity of $16.37 million for Q2 2026, down 29.9% from $23.34 million a year earlier and down 12.4% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences' Liabilities and Shareholders Equity came in at $21.44 million, down 9.2% from FY2024.
- Annual Liabilities and Shareholders Equity has declined for five consecutive years, with a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- In prior years, Emmaus Life Sciences' Liabilities and Shareholders Equity was $23.6 million in FY2024 (-32.9%), $35.18 million in FY2023 (-27.1%), $48.23 million in FY2022 (-15.0%) and $56.73 million in FY2021 (-4.7%).
- The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q3 2018.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last 11 quarters, with an average decline of 23.6% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2023, with growth of 12.4%; the weakest was Q2 2024, with a decline of 48.4%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $18.7 million (Q1 2026), $21.44 million (Q4 2025) and $20.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | 16.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.37 Mn |
| Mar 31, 2026 | 18.70 Mn |
| Dec 31, 2025 | 21.44 Mn |
| Sep 30, 2025 | 20.76 Mn |
| Jun 30, 2025 | 23.34 Mn |
| Mar 31, 2025 | 22.48 Mn |
| Dec 31, 2024 | 23.60 Mn |
| Sep 30, 2024 | 27.34 Mn |
| Jun 30, 2024 | 25.94 Mn |
| Mar 31, 2024 | 29.54 Mn |
| Dec 31, 2023 | 35.18 Mn |
| Sep 30, 2023 | 47.45 Mn |
| Jun 30, 2023 | 50.29 Mn |
| Mar 31, 2023 | 48.95 Mn |
| Dec 31, 2022 | 48.23 Mn |
| Sep 30, 2022 | 42.20 Mn |
| Jun 30, 2022 | 45.99 Mn |
| Mar 31, 2022 | 51.49 Mn |
| Dec 31, 2021 | 56.73 Mn |
| Sep 30, 2021 | 60.06 Mn |
API Access
Emmaus Life Sciences Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();